Life ScienceCompany
OREXIGEN Therapeutics Ownership
Who owns OREXIGEN Therapeutics?
OREXIGEN Therapeutics is owned by Nalpropion Pharmaceuticals. It was acquired on April 24, 2018.
Was OREXIGEN Therapeutics formerly PE-backed?
Yes. OREXIGEN Therapeutics was formerly owned by 2 private investors.
OREXIGEN Therapeutics Business Overview
Where is OREXIGEN Therapeutics headquartered?
OREXIGEN Therapeutics is headquartered in La Jolla, California.
What is OREXIGEN Therapeutics’ revenue?
OREXIGEN Therapeutics disclosed revenue of 89M USD for 2017 and 34M USD for 2016.
How many employees does OREXIGEN Therapeutics have?
OREXIGEN Therapeutics has 47 employees.
What sector is OREXIGEN Therapeutics in?
OREXIGEN Therapeutics is a life science company.
When was OREXIGEN Therapeutics founded?
OREXIGEN Therapeutics was founded in 2002.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 247 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 203 by strategics.